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patients are available. The potential impact of the
effects of lipid lowering on morbidity and morality in
patients with coronary artery disease was highlighted
by the Scandinavian Simvastatin Survival Study
(4S)'71. Patients with preserved exercise capacity are
often not considered for cardiac rehabilitation pro-
grammes. However, aside from learning how to cope
with the limitations imposed by the present state of
the disease, a second thrust of cardiac rehabilitation
is to prevent progression of the disease and future
deterioration of the quality of life by appropriate life
style changes and medical treatment'81. This can
be achieved by a multifactorial comprehensive
approach, as was shown by Haskell et a/.'9', and also
by lipid lowering171, in a low risk group of patients
with coronary artery disease.
Bypass surgery and PTCA are palliative procedures.
To improve prognosis on a long-term basis the under-
lying disease process needs to be altered to retard
progression, induce regression and prevent future
events. Various treatment measures'1"91 which are effec-
tive in achieving these goals can all be optimally applied
in a comprehensive rehabilitation programme. Thus,
cardiac rehabilitation with its multifactorial and multi-
disciplinary approach has gained greater importance,
even in patients suffering minimal distress and in those
with preserved exercise capacity.
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The elderly patient suffering from mitral stenosis repre-
sents a challenge to every cardiologist if the patient
becomes severely symptomatic despite adequate medical
therapy. If there is associated cardiac and non-cardiac
disease, operative mortality as a result of surgical com-
missurotomy or even mitral valve replacement is clearly
increased. On the other hand, a severely altered valve
morphology with heavy calcifications is frequently
found in older patients and limits short- and long-term
success of balloon commissurotomy. For the clinician it
is therefore important to know which subset of patients
would still profit from balloon commissurotomy. As a
direct comparison of surgical vs balloon commissur-
otomy in this age group is unfeasible and unethical
(surgery is often not an option), our knowledge has to be
based on retrospective studies. Such a retrospective
study is presented by lung et a/.''1 in this issue and sheds
some light on the problems of differential therapy of
calcified mitral stenosis. The important findings are: (1)
A total of 36% of the referred patients were excluded
from percutaneous balloon commissurotomy due to
either associated cardiac disease requiring surgery or
bicommissural calcifications. The latter was the only
morphological criteria used to exclude patients from the
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procedure apart from the usual contraindications. As
commissural splitting in the presence of commissural
calcification cannot be expected, such a decision seems
reasonable. If no commissural splitting can be achieved,
the initial result will be unsatisfactory121. (2) Although
the procedure is technically feasible in elderly patients
the complication rate regarding procedure-related death,
in-hospital mortality, pericardial tamponade, throm-
boembolism, severe mitral regurgitation and need for
surgical repair at the puncture site is substantial. This
finding is in accordance with other reports demonstrat-
ing relevant complications in the range of 16-27%13'4'
compared to 8% in the younger population in the
NHLBI registry151. (3) A sizeable percentage of poor
immediate results is to be expected varying from 28-
53<>/o[i,3,4] ^ s tjje definition of a poor result differs among
various studies (usually mitral valve area > 1-5 cm2 and
mitral regurgitation <2 + ), a direct comparison is diffi-
cult. The predictors of a poor outcome in this age group
are extensive valve calcification and prior surgical com-
missurotomy in lung's study. Other reports revealed
a smaller mitral valve area before the intervention, a
higher pulmonary resistance and the combination of low
echocardiographic score, low NYHA functional class
and inverse mitral valve area as the best predictors of
success'3'41. The prevalence of all these parameters is
strongly influenced by the duration and the extent of the
disease. Elderly patients will obviously have accumu-
lated multiple adverse factors since the time their disease
started with a rheumatic fever. (4) The long-term result,
defined as freedom from death, reintervention or sur-
gery, after balloon commissurotomy in this age group is
moderate; the event-free survival after 4 years was
54 ± 17%. An event-free survival together with a good
functional result (NYHA functional class I or II) after 4
years was found in 34 ± 16% only, which is similar to
Tuzcu's study (46 ± 7% after 3 years). A low NYHA
class, a low echocardiographic mitral valve score, lack of
calcification of the mitral valve, a good immediate result,
low left atrial, pulmonary artery and left ventricular end
diastolic pressures have all been shown to predict an
event-free survival11'4'61. Again, all these predictive
parameters are either a sign of advanced mitral valve
disease or are critically influenced by associated cardiac
disorders, such as coronary artery disease which is
highly prevalent in this age group in a Western society.
The clinical follow-up is therefore determined by the
unfavourable valve anatomy resulting in a significant
percentage of suboptimal results, with an increased risk
of restenosis on the one hand, and the extent of con-
comitant disorders on the other. (5) The peri-operative
mortality of the patients undergoing mitral valve re-
placement during the follow-up period is 20%, highlight-
ing the fact that surgery is often not the ideal procedure
in this age group. The specific valve prosthesis-related
side effects and complications will further influence the
long-term outcome in these operated patients.
Thus, balloon commissurotomy in the elderly patient
is above all a palliative procedure with an increased
complication rate, and acceptable immediate and mod-
erate long-term results. Nevertheless this procedure is a
practicable alternative to a surgical intervention in the
severely symptomatic, elderly patient with predomi-
nantly calcified mitral stenosis. The best results will be
achieved in patients with minimal calcifications in the
absence of concomitant disorders. But even if significant
calcifications are present, balloon commissurotomy can
at least produce a temporary clinical improvement, as
long as the calcifications are not located in both com-
missures. In the case of bicommissural calcifications,
surgery with mitral valve replacement seems to be the
only reasonable option, but carries an increased risk of
untoward events. Between the clearcut indications for
either surgery with valve replacement or balloon com-
missurotomy lies a gray zone where careful weighing of
the pros and cons in relation to a specific patient is
essential. Together with the patient's preference and the
knowledge of the merits of the two procedures a well
balanced decision about the way to proceed must be
reached for each patient.
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